From February 6, 2024 to March 31, 2024, the company has repurchased 1,796,900 shares, representing 0.29% for CNY 22.86 million. With this, the company has completed the repurchase of 1,796,900 shares, representing 0.29% for CNY 22.86 million under the buyback announced on February 6, 2024.
Maccura Biotechnology Co.Ltd
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.82 CNY | -1.00% | -6.49% | -14.93% |
Apr. 25 | Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023 | CI |
Apr. 24 | Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.93% | 1.07B | |
-6.66% | 12.1B | |
-4.07% | 8.14B | |
+6.01% | 5.72B | |
+28.13% | 5.51B | |
-59.44% | 2.72B | |
+8.04% | 2.59B | |
-7.19% | 2.34B | |
+21.84% | 2.11B | |
-8.15% | 1.79B |
- Stock Market
- Equities
- 300463 Stock
- News Maccura Biotechnology Co.Ltd
- Tranche Update on Maccura Biotechnology Co.Ltd's Equity Buyback Plan announced on February 6, 2024.